B. Liu
Qingdao University(CN)Handan College(CN)Zhejiang Chinese Medical University(CN)Qingdao University of Science and Technology(CN)Harbin Medical University(CN)China National Nuclear Corporation(CN)National Health and Family Planning Commission(CN)Ministry of Education(SA)Panzhihua University(CN)People's Hospital of Cangzhou(CN)Hunan Cancer Hospital(CN)Affiliated Hospital of Shandong University of Traditional Chinese Medicine(CN)Tang Hospital(CN)National Nuclear Corporation (United Kingdom)(GB)Heilongjiang University(CN)Hubei University of Technology(CN)College of Marin(US)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Gastrointestinal Tumor Research and Treatment, Radiomics and Machine Learning in Medical Imaging, Cancer Research and Treatments
Most-Cited Works
- → Thermo and pH Dual‐Responsive Nanoparticles for Anti‐Cancer Drug Delivery(2007)265 cited
- → Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis(2011)78 cited
- → LBA2 Sintilimab plus bevacizumab biosimilar vs sorafenib as first-line treatment for advanced hepatocellular carcinoma (ORIENT-32)2(2020)30 cited
- → Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis(2024)20 cited
- → Improving soil properties and Sesbania growth through combined organic amendment strategies in a coastal saline-alkali soil(2025)15 cited
- → 1445P CS1001, an anti-PD-L1 antibody, combined with standard of care (SOC) chemotherapy for first line (1L) advanced GC/GEJ and ESCC: Preliminary results from 2 phase Ib cohorts of CS1001-101 study